Nasdaq · CIK 0001162194
LAB STANDARD BIOTOOLS INC.
Insider trading from SEC Form 4. Last filing Mar 24, 2025. Close $0.69 on Oct 9, 2026, +8% from the 52-week low and -59% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
5
with a Form 4 at this company
Price and insider trades, last year
LABOct 9, 2026 · close 0.69
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at STANDARD BIOTOOLS INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | Casdin Partners Master Fund, L.P. director, owner buy | $5.1M 4,820,959 shares | +9% | - |
Transactions
The last 12 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 21, 2025 | Michael Egholm President & CEO | AGrant or award Common Stock | +1,188,333 | $0.00 | $0 | 2,636,006 | Mar 24, 2025 |
| Mar 21, 2025 | Hanjoon Alex Kim Chief Financial Officer | AGrant or award Common Stock | +338,333 | $0.00 | $0 | 892,098 | Mar 24, 2025 |
| Mar 21, 2025 | Michael Egholm President & CEO | AGrant or award Stock Option (Right to buy)derivative | +1,782,500 | $0.00 | $0 | 1,782,500 | Mar 24, 2025 |
| Mar 21, 2025 | Hanjoon Alex Kim Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +507,500 | $0.00 | $0 | 507,500 | Mar 24, 2025 |
| Feb 28, 2025 | Casdin Partners Master Fund, L.P. director, owner | POpen-market purchase Common Stockindirect: See footnote | +4,820,959 | $1.07 | $5.1M | 58,846,780 | Mar 4, 2025 |
| Feb 28, 2025 | Thomas D. Carey director | AGrant or award Common Stock | +56,338 | $1.07 | $60k | 99,466 | Mar 4, 2025 |
| Feb 28, 2025 | Troy Cox director | AGrant or award Common Stock | +62,910 | $1.07 | $67k | 224,730 | Mar 4, 2025 |
| Feb 28, 2025 | Casdin Partners Master Fund, L.P. director, owner | JOther Common Stockindirect: See footnote | +545,000 | $1.07 | $580k | 59,391,780 | Mar 4, 2025 |
| Feb 28, 2025 | Casdin Partners Master Fund, L.P. director, owner | JOther Common Stockindirect: See footnote | -545,000 | $1.07 | $580k | 0 | Mar 4, 2025 |
| Feb 28, 2025 | Casdin Partners Master Fund, L.P. director, owner | AGrant or award Common Stock | +58,215 | $1.07 | $62k | 2,806,470 | Mar 4, 2025 |
| Feb 20, 2025 | Michael Egholm President & CEO | FTax withholding Common Stock | -31,031 | $1.39 | $43k | 1,447,673 | Feb 24, 2025 |
| Nov 20, 2024 | Michael Egholm President & CEO | FTax withholding Common Stock | -28,795 | $1.51 | $43k | 1,473,704 | Nov 21, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Thomas D. Careydirector
- Casdin Partners Master Fund, L.P.director, owner
- Troy Coxdirector
- Michael EgholmPresident & CEO
- Hanjoon Alex KimChief Financial Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.